期刊文献+

Graves’病患者^(131)I治疗前后TMA、TGA的变化与甲状腺大小的关系

Study on the Relationship Between the Magnitude of Increase of Serum TMA,TGA Contents and the Size of Goiter in Patients with Graves' Disease After Treatment with ^(131)I
下载PDF
导出
摘要 目的:探讨Graves’病患者131I治疗前后TGA、TMA的变化与甲状腺大小之间的关系。方法:327例Graves’病患者按甲状腺大小分为三组。甲状腺Ⅰ°肿大组97人。甲状腺Ⅱ°肿大组128人;甲状腺Ⅲ°肿大组102人。用化学发光法测定患者治疗前及治疗后第6月的TGA、TMA值,并进行比较。结果:甲状腺Ⅰ°肿大组治疗前后TGA、TMA值变化不明显(P>0.05),早发甲减率21.44%;甲状腺Ⅱ°肿大组,治疗后TGA、TMA值比治疗前升高(P<0.01),早发甲减率27.15%;甲状腺Ⅲ°肿大组,治疗后TGA、TMA值比治疗前明显升高(P<0.01),早发甲减率30.07%。结果还显示,治疗后TGA、TMA值随着治疗前甲状腺越大,值的升高越明显,早发甲减几率越高。结论:Graves’病患者甲状腺越大,131I治疗后TGA、TMA升高越明显,早发甲减几率越高。 Objective To study the relationship between changes of serum TMA,TGA levels and the size of goiter in patients with Graves' disease treated with 131I.Methods Serum TGA,TMA levels were measured with CLIA in 327 patients with Graves' disease both before and six months after 131I treatment.These 327 patients were of three groups: Goiter Ⅰ° n=97,Ⅱ° n=128,Ⅲ° n=102.Results In patients with Ⅰ° goiter,the serum TGA and TMA levels were only insignificantly increased after the 131I treatment with an early hypothroidism rate of 21.44%.In patients with Ⅱ° goiter,the serum TGA and TMA levels were significantly increased after treatment(P0.01) with an early hypothyroidism rate of 27.15%.In patients with Ⅲ° goiter,the post-treatment serum TGA and TMA levels were futhur elevated and the early hypothyroidism rate was also further increased to 30.07%.Conclusion Much more increase of serum TGA and TMA levels was associated with larger goiter and higher early hypothyroism rate in patients with Graves' disease treated with 131I.
作者 郑芳 谭庆玲
出处 《放射免疫学杂志》 CAS 2009年第6期622-623,共2页 Journal of Radioimmanology
关键词 Graves’病 甲状腺微粒体抗体 甲状腺球蛋白抗体 甲状腺肿 Graves' disease TMA TGA goiter
  • 相关文献

参考文献5

二级参考文献24

  • 1Giovanella L, De palma D, Ceriani L, et al. Radioiodine treatment of hyperthyroidism using a simplified dosimetric approach: Clinical results[J]. Radiol Med(Torino), 2000,100(6): 480-483.
  • 2Ghadban WK, Zirie MA, AL-Khateeb DA, et al. Radioiodine treatment of hyperthyroidism: success rate and influence of thyrostatic medication[J]. Saudi Med J, 2003, 24(4): 347-351.
  • 3Ahmad AM, Ahmad M, Young ET. Objective estimates of the probability of developing hypothyroidism following radioactive iodine treatment of thyrotoxicosis [J]. Eur J Endocrinol, 2002, 146(6):767-775.
  • 4Holm LE, Lundell G, Israesson A, et al. Incidence of hypothyroidism occurring long after iodine-131 therapy for hyperthyroidism[J]. J Nucl Med, 1982, 23(2): 103-107.
  • 5Bringmann IM,Van leeuwen BL, Hennemann G, et al. Outcome of treatment of hyperthyroidism[J]. J Endocrinol Invest, 1999, 22(4):250-256.
  • 6Uy HL, Reasner CA, Samuels MH. Pattern of recovery of the hypothalamic-pituitary-thyroid axis following radioactive iodine therapy in patients with Graves disease[J]. Am J Med, 1995, 99: 173-179.
  • 7Gomez N, Gomez JM, Orti A, et al. Transient hypothyroidism af-ter iodine-131 therapy for Graves' disease[J]. J Nucl Med, 1995, 36(9): 1539-1542.
  • 8Sabri O, Schulz G, Zimny M, et al. Determination of factors affecting the therapeutic outcome of radioiodine therapy in patients radioactive iodine with Graves' disease [J ]. Nuklearmedizin, 1998,37: 83-84.
  • 9Gibold L, Delisle MJ, Maes B, et al. Treatment of hyperthyroidism by radioactive iodine: Development of methods and difficulties inthe surveillance[J]. Presse Med, 1988, 17(17): 1397-1400.
  • 10Chiovato L, Fiore E, Vitti P, et al. Outcome of thyroid function in Grave′s patient with radioidin: role of thyroid-stimulating and thyrotropin-blocking antibodies and radioiodine-induced thyriod damage[J]. J Clin Endocrinol Meted, 1998, 83(1): 40-46.

共引文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部